Paul H. Kim

CEO & Managing Partner of Forward Equity Partners, Board Observer
Mr. Kim brings over 28 years of experience in healthcare investment and biotech corporate executive roles.  He has founded both Forward Equity Partners and Medivate Partners – during which he led 15 cross-border PE & VC investments in the US & EU.  Previously, Mr. Kim served as the Head of Novartis Venture Fund Korea (NVFK) – first global pharmaceutical fund to focus solely on innovative Asian biotech investments. Before Novartis, Mr. Kim served as co-founder and head of POSCO BioVentures – $62M Venture Fund focused on US & EU biotech investments on behalf of POSCO, $40B steel conglomerate.  He has most recently served on the Boards of WCCT Global (acquired by Novo/Altasciences) and Genopis (acquired by Wacker).
Mr. Kim received his bachelor’s degree in Molecular Cell Biology from U.C. Berkeley and is a graduate of Life Sciences Executive program.